Editorial: Organ crosstalk in the pathophysiology and treatment of type-2 diabetes

Estela Lorza-Gil; Bilgen Ekim; Gencer Sancar

doi:10.3389/fendo.2024.1379994

Editorial: Organ crosstalk in the pathophysiology and treatment of type-2 diabetes

Front Endocrinol (Lausanne). 2024 Feb 22:15:1379994. doi: 10.3389/fendo.2024.1379994. eCollection 2024.

Authors

Estela Lorza-Gil^{1

2

3}, Bilgen Ekim^{3

4}, Gencer Sancar^{1

2

3}

Affiliations

¹ Department of Internal Medicine IV, Division of Endocrinology, Diabetology and Nephrology, University Hospital Tübingen, Tübingen, Germany.
² Institute for Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
³ German Center for Diabetes Research (DZD e. V.), Neuherberg, Germany.
⁴ Joint Heidelberg-Institute for Diabetes and Cancer (IDC) Helmholtz Center Munich Translational Diabetes Program, Department of Internal Medicine, Heidelberg University Hospital, Heidelberg, Germany.

No abstract available

Keywords: biomarkers for diagnosis and prognosis; cardiomyokines; diabetes; diabetic kidney disease; extracellular vesicles (EVs); gestational diabetes; organ cross talk.

Publication types

Editorial

MeSH terms

Diabetes Mellitus, Type 2* / therapy
Extracellular Vesicles*
Humans